NCT06334861View on ClinicalTrials.gov

Multidisciplinary Hospital-Territory Vaccine Center: a Model for Achieving the Herpes Zoster Vaccine Coverage

CompletedOBSERVATIONAL
Enrollment

178

Participants

Timeline

Start Date

June 23, 2022

Primary Completion Date

May 15, 2024

Study Completion Date

July 30, 2024

Conditions
Herpes Zoster
Interventions
BIOLOGICAL

Herpes Zoster adjuvanted recombinant vaccine

patients will receive two doses of vaccine with an interval between the first and second dose of 2 months

Trial Locations (1)

00168

Fondazione Policlinico Universitario A. Gemelli - UCSC, Roma

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER